December 20 Product: Zealands glepaglutide Indication: Short bowel syndrome The FDA on Thursday shot down Zealand Pharmas aspirations to use its investigational GLP-2 analog glepaglutide for the treatment of short bowel syndrome
Petakh P, Kamyshna I, Kamyshnyi A
Long-term alcohol abuse and addiction can lead to chronic sleep problems, leading to irritability, anxiety, and depression
Food Control 2016;60:6487
Migraine medications like Frova (frovatriptan), Imitrex (sumatriptan), and Relpax (eletriptan) Oral sulfonylureas-class drugs like Amaryl (glimepiride), Glynase (glyburide), and Glucotrol (glipizide) used to treat type 2 diabetes Azulfidine (sulfasalazine) used to treat Crohns disease, ulcerative colitis, and rheumatoid arthritis G6PD In addition, people with a glucose 6 phosphate dehydrogenase (G6PD) deficiency (a lack of enough of a specific red blood cell enzyme) are at risk of developing hemolytic anemia
Also Read: